{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:01:01Z","timestamp":1785002461565,"version":"3.55.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Medical and Health Science and Technology Development Project of Shandong Provincial","award":["2019WS341"],"award-info":[{"award-number":["2019WS341"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160632"],"award-info":[{"award-number":["82160632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2019MS08182"],"award-info":[{"award-number":["2019MS08182"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Medical Research and Clinical New Technology Promotion Project of Inner Mongolia Association","award":["YSXH2024KYF099"],"award-info":[{"award-number":["YSXH2024KYF099"]}]},{"name":"Science and Technology Program of Hulunbuir","award":["SF2023017"],"award-info":[{"award-number":["SF2023017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Atherosclerosis significantly contributes to global cardiovascular mortality. Macrophage polarization and foam cell formation via oxidized low-density lipoprotein uptake are key drivers of plaque progression and instability. Targeting these processes may offer a promising therapeutic approach. This study aimed to investigate the potential therapeutic effects of Shanhuang Jiangzhi tablets (SHJZT) using apolipoprotein E-deficient mice and RAW264.7 macrophage-based experimental models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Key assays, including oxidized low-density lipoprotein-induced foam cell formation and lipopolysaccharide (LPS)-induced macrophage polarization, were performed to elucidate the regulatory effects of SHJZT, with a particular focus on the reactive oxygen species (ROS)\/Toll-like receptor 4 (TLR4)\/NF-\u03baB signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>In vivo, SHJZT treatment significantly attenuated atherosclerotic lesion development, improved lipid metabolism, and enhanced reverse cholesterol transport by regulating ABCA1 and ABCG1 expression, thereby suppressing foam cell formation. Furthermore, SHJZT promoted macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. Mechanistic investigations revealed that SHJZT mitigated LPS-induced ROS production and inhibited the activation of the TLR4\/NF-\u03baB signaling cascade in vitro. Specifically, SHJZT downregulated key pathway components, including TLR4, MYD88, and phosphorylated NF-\u03baB p65, in high-fat diet-induced atherosclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SHJZT exerts anti-atherosclerotic effects by modulating macrophage polarization and inhibiting foam cell formation through the suppression of ROS\/TLR4\/NF-\u03baB signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag079","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:30:26Z","timestamp":1783337426000},"source":"Crossref","is-referenced-by-count":0,"title":["Shanhuang Jiangzhi tablets mitigate atherosclerosis by modulating macrophage polarization and inhibiting foam cell formation via the ROS\/TLR4\/NF-\u03baB pathway"],"prefix":"10.1093","volume":"78","author":[{"given":"Yingwei","family":"Chang","sequence":"first","affiliation":[{"name":"Suzhou Medical College of Soochow University, Soochow University , Suzhou 215000 ,","place":["China"]},{"name":"Department of Geriatrics, Qingdao Huangdao District Central Hospital , Qingdao 266071 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Basic Medicine, Shandong University , Jinan 250021 ,","place":["China"]},{"name":"School of Health and Life Sciences, University of Health and Rehabilitation Sciences , Qingdao 266071 ,","place":["China"]},{"name":"Institute of Neurobiology, Binzhou Medical University , Yantai 264003 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Binzhou Medical University , Yantai 264003 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Medicine School, Qingdao University , Qingdao 266071 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Lv","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Binzhou Medical University , Yantai 264003 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hulunbuir Zhongmeng Hospital , Hulunbuir 021000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"He","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Xing\u2019an Meng People\u2019s Hospital , Ulanhot 137400 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Yantai Affiliated Hospital of Binzhou Medical University , Yantai 264100 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5505-0097","authenticated-orcid":false,"given":"Xiuwen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hulunbuir Zhongmeng Hospital , Hulunbuir 021000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"2026072513183329800_ref1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026072513183329800_ref2","first-page":"2022","volume-title":"Monitoring Health for the SDGs, Sustainable Development Goals","author":"World Health Organization, World Health Statistics","year":"2022"},{"key":"2026072513183329800_ref3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2026072513183329800_ref4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","article-title":"Macrophage polarization and metabolism in atherosclerosis","volume":"14","author":"Hou","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026072513183329800_ref5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejvs.2012.08.005","article-title":"Macrophage subtypes in symptomatic carotid artery and femoral artery plaques","volume":"44","author":"Shaikh","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026072513183329800_ref6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.freeradbiomed.2022.02.010","article-title":"Macrophage polarization by potential nutraceutical compounds: a strategic approach to counteract inflammation in atherosclerosis","volume":"181","author":"Sottero","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026072513183329800_ref7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in atherosclerosis regression","volume":"40","author":"Barrett","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026072513183329800_ref8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"2026072513183329800_ref9","doi-asserted-by":"publisher","first-page":"682853","DOI":"10.3389\/fimmu.2021.682853","article-title":"Metformin, macrophage dysfunction and atherosclerosis","volume":"12","author":"Feng","year":"2021","journal-title":"Front Immunol"},{"key":"2026072513183329800_ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2009.10.002","article-title":"Macrophage cholesteryl ester mobilization and atherosclerosis","volume":"52","author":"Ghosh","year":"2010","journal-title":"Vasc Pharmacol"},{"key":"2026072513183329800_ref11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026072513183329800_ref12","doi-asserted-by":"publisher","first-page":"E884","DOI":"10.1073\/pnas.1525639113","article-title":"TLR4\/MD-2 activation by a synthetic agonist with no similarity to LPS","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026072513183329800_ref13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/ATVBAHA.108.176644","article-title":"Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice","volume":"29","author":"Manning-Tobin","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026072513183329800_ref14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/antiox10020313","article-title":"Functions of ROS in macrophages and antimicrobial immunity","volume":"10","author":"Herb","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2026072513183329800_ref15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s41043-025-01057-0","article-title":"A retrospective cohort study on the clinical efficacy of Shanhuang Jiangzhi tablets and atorvastatin calcium tablets in the treatment of carotid atherosclerosis","volume":"44","author":"Chang","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"2026072513183329800_ref16","doi-asserted-by":"publisher","first-page":"155526","DOI":"10.1016\/j.phymed.2024.155526","article-title":"Morus alba L. (Sangzhi) alkaloids mitigate atherosclerosis by regulating M1\/M2 macrophage polarization","volume":"128","author":"Peng","journal-title":"Phytomedicine"},{"key":"2026072513183329800_ref17","doi-asserted-by":"publisher","first-page":"107486","DOI":"10.1016\/j.phrs.2024.107486","article-title":"Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation","volume":"210","author":"Hu","journal-title":"Pharmacol Res"},{"key":"2026072513183329800_ref18","doi-asserted-by":"publisher","first-page":"200440","DOI":"10.1016\/j.ijcrp.2025.200440","article-title":"Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy","volume":"26","author":"Sharma","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026072513183329800_ref19","doi-asserted-by":"publisher","first-page":"155827","DOI":"10.1016\/j.phymed.2024.155827","article-title":"Guizhitongluo tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1\/NLRP3 mediated macrophage pyroptosis","volume":"132","author":"Pan","year":"2024","journal-title":"Phytomedicine"},{"key":"2026072513183329800_ref20","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1097\/CM9.0000000000002482","article-title":"Methyl CpG binding domain protein 2 (MBD2) in inflammation","volume":"135","author":"Lei","year":"2022","journal-title":"Chin Med J"},{"key":"2026072513183329800_ref21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026072513183329800_ref22","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"key":"2026072513183329800_ref23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026072513183329800_ref24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2026072513183329800_ref25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European atherosclerosis society consensus panel statement","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"2026072513183329800_ref26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.phrs.2018.07.012","article-title":"Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine","volume":"135","author":"Qiao","year":"2018","journal-title":"Pharmacol Res"},{"key":"2026072513183329800_ref27","doi-asserted-by":"publisher","first-page":"104306","DOI":"10.1016\/j.phrs.2019.104306","article-title":"Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent","volume":"146","author":"Hao","year":"2019","journal-title":"Pharmacol Res"},{"key":"2026072513183329800_ref28","doi-asserted-by":"publisher","first-page":"153812","DOI":"10.1016\/j.phymed.2021.153812","article-title":"Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4\/MyD88\/NF-\u03baB pathway regulation","volume":"93","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"key":"2026072513183329800_ref29","doi-asserted-by":"publisher","first-page":"105639","DOI":"10.1016\/j.phrs.2021.105639","article-title":"Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPAR\u03b3-LXR\u03b1-ABCA1\/ABCG1 pathway","volume":"169","author":"Zheng","year":"2021","journal-title":"Pharmacol Res"},{"key":"2026072513183329800_ref30","doi-asserted-by":"publisher","first-page":"117339","DOI":"10.1016\/j.jep.2023.117339","article-title":"Shenlian extract improves atherosclerosis by relieving adventitial inflammation","volume":"320","author":"Han","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"2026072513183329800_ref31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s41043-023-00482-3","article-title":"Comparison of the efficacy and safety of Shanhuang Jiangzhi tablets and atorvastatin in the treatment of patients with hyperlipidaemia","volume":"42","author":"Sun","year":"2023","journal-title":"J Health Popul Nutr"},{"key":"2026072513183329800_ref32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2026072513183329800_ref33","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","article-title":"Macrophage diversity and polarization in atherosclerosis: a question of balance","volume":"29","author":"Mantovani","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026072513183329800_ref34","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/j.1582-4934.2010.01121.x","article-title":"Macrophages heterogeneity in atherosclerosis - implications for therapy","volume":"14","author":"Wilson","year":"2010","journal-title":"J Cell Mol Med"},{"key":"2026072513183329800_ref35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"2026072513183329800_ref36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"St\u00f6ger","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026072513183329800_ref37","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.redox.2024.103318","article-title":"ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages","volume":"76","author":"Rui","year":"2024","journal-title":"Redox Biol"},{"key":"2026072513183329800_ref38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jare.2024.05.011","article-title":"ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque","volume":"70","author":"Zhang","year":"2024","journal-title":"J Adv Res"},{"key":"2026072513183329800_ref39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-025-02603-0","article-title":"Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK\/mTOR pathway-mediated autophagy-related macrophage polarization","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"2026072513183329800_ref40","doi-asserted-by":"publisher","first-page":"114741","DOI":"10.1016\/j.celrep.2024.114741","article-title":"Integrated metabolic-transcriptomic network identifies immunometabolic modulations in human macrophages","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep"},{"key":"2026072513183329800_ref41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","article-title":"Targeting foam cell formation in atherosclerosis: Therapeutic potential of natural products","volume":"71","author":"Wang","year":"2019","journal-title":"Pharmacol Rev"},{"key":"2026072513183329800_ref42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","article-title":"Atherosclerosis: successes, surprises, and future challenges","volume":"118","author":"Libby","year":"2016","journal-title":"Circ Res"},{"key":"2026072513183329800_ref43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"2026072513183329800_ref44","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/cvr\/cvq116","article-title":"TLR2 ligands induce cardioprotection against ischaemia\/reperfusion injury through a PI3K\/Akt-dependent mechanism","volume":"87","author":"Ha","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2026072513183329800_ref45","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026072513183329800_ref46","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3390\/molecules26206252","article-title":"Phytochemistry, ethnopharmacological uses, biological activities, and therapeutic applications of Cassia obtusifolia L.: a comprehensive review","volume":"26","author":"Ali","year":"2021","journal-title":"Molecules"},{"key":"2026072513183329800_ref47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/molecules22010028","article-title":"Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on \u03b1-glucosidase and human protein tyrosine phosphatases 1B","volume":"22","author":"Jung","year":"2016","journal-title":"Molecules"},{"key":"2026072513183329800_ref48","doi-asserted-by":"publisher","first-page":"e35106","DOI":"10.1097\/MD.0000000000035106","article-title":"Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: network pharmacology and molecular docking analysis","volume":"102","author":"Niu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026072513183329800_ref49","doi-asserted-by":"publisher","first-page":"e14457","DOI":"10.1111\/jfbc.14457","article-title":"Elucidation of active ingredients and mechanism of action of hawthorn in the prevention and treatment of atherosclerosis","volume":"46","author":"Li","year":"2022","journal-title":"J Food Biochem"},{"key":"2026072513183329800_ref50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1211\/0022357021468","article-title":"Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil\u2019s claw root and garlic or salmon oil for antioxidant capacity","volume":"55","author":"Betancor-Fern\u00e1ndez","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"2026072513183329800_ref51","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/molecules30071486","article-title":"Bioactive molecules from tropical American plants: potential anti-inflammatory agents for cytokine storm management","volume":"30","author":"Plazas","year":"2025","journal-title":"Molecules"},{"key":"2026072513183329800_ref52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000227819","article-title":"Asymmetric dimethylarginine impairs glucose utilization via ROS\/TLR4 pathway in adipocytes: an effect prevented by vitamin E","volume":"24","author":"Yang","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"2026072513183329800_ref53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.canlet.2014.08.018","article-title":"Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-\u03baB signaling","volume":"354","author":"Duan","year":"2014","journal-title":"Cancer Lett"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/7\/rgag079\/70037949\/rgag079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/7\/rgag079\/70037949\/rgag079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:18:41Z","timestamp":1784999921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag079\/8741895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag079","relation":{},"ISSN":["2042-7158"],"issn-type":[{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"rgag079"}}